Your fact-checks will appear here
Adenoviral vaccines as a type of COVID-19 vaccine associated with rare autoimmune conditions
Different vaccine platforms and dosing regimens do influence whether and for how long fragments of spike protein or spike subunits are detectable in blood, but the picture is inconsistent because dete...
Published pharmacology and immunology studies show replication-defective adenoviral vector genomes commonly persist at low levels in tissues—most consistently at the injection site (muscle), in liver ...
A set of converging hypotheses and small clinical studies propose that spike protein produced after COVID-19 mRNA or vector vaccination can, in rare cases, contribute to myocardial inflammation and th...